Abacavir +Lamivudine 600/300mg Tablet

Abacavir +Lamivudine 600/300mg Tablet is a fixed-dose antiretroviral medication widely used in the treatment of human immunodeficiency virus (HIV) infection. This combination belongs to the nucleoside reverse transcriptase inhibitor (NRTI) class and is commonly prescribed as part of combination antiretroviral therapy (ART). Abacavir works by blocking viral DNA synthesis, while lamivudine prevents the virus from replicating within healthy immune cells.

This pharmaceutical product helps reduce HIV viral load, improve immune response, and slow disease progression when taken regularly under medical supervision. The once-daily oral tablet formulation supports better treatment adherence and consistent therapeutic outcomes. The Abacavir + Lamivudine 600/300 mg Tablet is suitable for adult and adolescent patients based on clinical evaluation.

This product ensures safety, stability, and reliable efficacy. Although it does not cure HIV, it plays a vital role in long-term HIV management and helps patients maintain a better quality of life. For optimal benefits, this antiretroviral product should be used exactly as prescribed by a healthcare professional and as part of a complete HIV treatment regimen.

Product Features

• Combination product containing Abacavir 600mg and Lamivudine 300mg
• Belongs to the nucleoside reverse transcriptase inhibitor (NRTI) class
• Used as part of a combination antiretroviral therapy (ART)
• Helps control HIV replication and reduce viral load
• Once-daily oral tablet for improved treatment adherence

How It Helps

• Inhibits HIV reverse transcriptase enzyme to prevent viral replication
• Helps lower the HIV viral load in the bloodstream
• Supports immune system recovery and function
• Slows the progression of HIV infection when used consistently